Max Healthcare Institute Limited (NSE:MAXHEALTH)

Max Healthcare Institute Income Statement

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Operating Revenue	75,131	70,285	54,060	45,626	39,366	25,080
Revenue	75,131	70,285	54,060	45,626	39,366	25,080
Revenue Growth (YoY)	32.65%	30.01%	18.49%	15.90%	56.96%	136.82%
Cost of Revenue	28,376	26,511	20,529	17,314	17,481	12,324
Gross Profit	46,755	43,774	33,531	28,312	21,885	12,755
Selling, General & Admin	15,736	14,747	11,169	9,863	8,729	5,657
Other Operating Expenses	10,794	10,157	7,159	5,887	3,365	2,927
Operating Expenses	30,397	28,499	20,778	18,072	14,305	10,325
Operating Income	16,358	15,275	12,753	10,240	7,580	2,431
Interest Expense	-1,797	-1,488	-445.6	-713.2	-900.1	-1,710
Interest & Investment Income	1,144	1,172	1,562	1,124	750.9	767.3
Earnings From Equity Investments	-	-	-	-	-	-230.5
Currency Exchange Gain (Loss)	-7	-7	3	-2.4	-3.4	178.8
Other Non Operating Income (Expenses)	250.7	204.4	41.6	86.7	207.3	67.4
EBT Excluding Unusual Items	15,949	15,158	13,914	10,735	7,634	1,504
Merger & Restructuring Charges	-	-	-	-	-90.3	-377.8
Gain (Loss) on Sale of Assets	1.1	1.1	4.5	13.3	-30.6	-2.4
Asset Writedown	-	-	-	-	-0.6	-81.4
Other Unusual Items	-1,095	-1,095	-265.4	-111.2	-123.8	-1,959
Pretax Income	14,855	14,064	13,653	10,637	7,389	-917
Income Tax Expense	3,379	3,305	3,077	-397.9	1,339	458.5
Earnings From Continuing Operations	11,476	10,759	10,576	11,035	6,051	-1,376
Net Income to Company	11,476	10,759	10,576	11,035	6,051	-1,376
Net Income	11,476	10,759	10,576	11,035	6,051	-1,376
Net Income to Common	11,476	10,759	10,576	11,035	6,051	-1,376
Net Income Growth	8.90%	1.73%	-4.16%	82.38%	-	-
Shares Outstanding (Basic)	972	972	972	970	967	863
Shares Outstanding (Diluted)	978	977	975	972	969	863
Shares Change (YoY)	0.20%	0.20%	0.39%	0.24%	12.30%	47.77%
EPS (Basic)	11.81	11.07	10.89	11.38	6.25	-1.59
EPS (Diluted)	11.74	11.01	10.84	11.36	6.24	-1.59
EPS Growth	8.70%	1.57%	-4.58%	82.05%	-	-
Free Cash Flow	-	4,938	3,357	9,485	1,872	-5.6
Free Cash Flow Per Share	-	5.05	3.44	9.76	1.93	-0.01
Dividend Per Share	-	1.500	1.500	1.000	-	-
Dividend Growth	-	-	50.00%	-	-	-
Gross Margin	62.23%	62.28%	62.02%	62.05%	55.59%	50.86%
Operating Margin	21.77%	21.73%	23.59%	22.44%	19.25%	9.69%
Profit Margin	15.27%	15.31%	19.56%	24.19%	15.37%	-5.49%
Free Cash Flow Margin	-	7.03%	6.21%	20.79%	4.75%	-0.02%
EBITDA	19,637	18,312	14,819	12,226	9,465	3,896
EBITDA Margin	26.14%	26.05%	27.41%	26.80%	24.04%	15.53%
D&A For EBITDA	3,279	3,037	2,066	1,986	1,886	1,465
EBIT	16,358	15,275	12,753	10,240	7,580	2,431
EBIT Margin	21.77%	21.73%	23.59%	22.44%	19.25%	9.69%
Effective Tax Rate	22.75%	23.50%	22.54%	-	18.12%	-
Revenue as Reported	76,706	71,841	55,830	47,018	40,588	26,194
Advertising Expenses	-	-	-	-	446.2	167.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.